Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-12-02

Clinical Trial Update: Functional Brain Imaging and Employment in First-Episode Psychotic Patients Treated With Risperdal [Phase 4]

View source ↗

Summary

A Phase 4 trial assessing functional brain imaging and employment outcomes in first-episode schizophrenia patients treated with Risperdal has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Risperdal (risperidone)

Snippet

Sponsor: Duke University | Conditions: Schizophrenia | Phase 4 | Status: TERMINATED